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Microarray technologies widen our comprehension of the major structural and metabolic 
transformations which affect the myometrium from the very beginning of pregnancy until 
parturition. The results are coherent with the mass of information which was accumulated 
previously, primarily on the basis of studies of selected critical factors. They highlight the 
activation of precise signaling pathways, some of which may have been previously under 
evaluated. The remodelling and maturation processes that the myometrium undergoes in 
pregnancy appear clearly as phenomenon's which last during the full course of gestation. 
Comparatively, the onset of labor is perhaps the phenomenon which remains the least well 
described by these methods of analysis. Nevertheless, genomic studies constitute a necessary 
first step of orientation and help establishing new links between the generic signaling 
pathways that are activated during the normal or pathological gestation. These studies also 
represent an indicative step that will have to be paralleled, in the future, with the results of the 
systematic proteomic analysis of the myometrium. 
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Parturition encompasses composite physiological processes that require synchronization of 
uterine contractions, cervical dilatation and fetal membrane rupture. The mechanisms by 
which parturition is triggered remain unknown but they are, as all developmental processes, 
the results of timely coordinated biochemical and physiological steps. Over the past decades, 
reductionist approaches have investigated the cellular and molecular bases of these 
developmental changes and focused on assessing the regulation of selected critical factors 
involved in the onset of labor. 
 
Recently, the near-entire genomic sequence of the human and several model animals have 
provided the opportunity to enhance our understanding of the relationships between genes, 
phenotypes and global transcriptional status. Oligonucleotides or DNA microarray 
technologies allow the examination of the function of thousands of genes at once and in 
parallel, thereby providing an “assay” of the transcriptional status of cells or tissues in a wide 
variety of physiological or pathophysiological situations (Dunckley et al., 2005). In the 
context of uncomplicated or complicated pregnancy and parturition, their interest is to obtain 
a molecular snapshot of the expression profile of gene transcripts as a function of the time-
dependent process regulating myometrial activity. 
 
Functional genomic studies during pregnancy 
 
Functional genomics has arrived at the study of parturition in different species: mice (Bethin 
et al., 2003, Salomonis et al., 2005), rats (Girotti & Zingg, 2003), human (Bethin et al., 2003, 
Chan et al., 2002, Charpigny et al., 2003, Esplin et al., 2005, Havelock et al., 2005, Keelan et 
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al., 2003, Marvin et al., 2002a, 2002b, Tashima et al., 2002), and different tissues: 
myometrium (Aguan et al., 2000, Bethin et al., 2003, Chan et al., 2002, Charpigny et al., 
2003, Esplin et al., 2005, Havelock et al., 2005, Salomonis et al., 2005), fetal membranes 
(Chen et al., 2002, Keelan et al., 2003, Marvin et al., 2002a, 2002b, Muhle et al., 2001, 
Tashima et al., 2002), trophoblast (Chen et al., 2002, Kato et al., 2002). Various 
methodologies have been used: Suppression Subtractive Hybridization (SSH) (Chan et al., 
2002) or microarrays for most of the previous cited studies. All investigators have reported 
genes differentially regulated during parturition (Romero et al., 2002) and multiple novel 
candidate markers for preterm labor (Chan et al., 2002, Marvin et al., 2002a, 2002b, Wu et 
al., 1999) or for premature rupture of membranes (Tashima et al., 2002). They contributed to 
shed light on specific pathophysiological issues like the patterns of expression of cytokines in 
the fetal membranes and decidua particularly in the presence of intrauterine infection (Keelan 
et al., 2003) or on the induction of enzymes for prostaglandin synthesis (Bethin et al., 2003). 
Groups of genes with yet unknown functional connection to these pathologies were also 
found coordinately expressed. This was emphasized in animal studies which allow to explore 
the global pattern of gene expression  and their co-regulation on the basis of their genomic 
location over the full time-course of myometrial transformation (i.e. pregnancy) or following 
experimentally-controlled infection (Girotti & Zingg, 2003, Muhle et al., 2001, Salomonis et 
al., 2005, Wu et al., 1999). 
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Computational methods have significantly helped to the interpretation of gene profiling 
experiments by delineating clusters of genes sharing coherent expression features (Claverie, 
1999). During the last five years, statistical methods and data analysis for array studies have 
progressed enormously and today an “ideal” study should now incorporate i) careful research 
designs (differential expression or cross sectional studies), ii) statistical methods 
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incorporating background adjustment and normalization of data, assessment of differential 
expression after determining sample size to control the proportion of positive calls that are 
false positives (False Discovery rate), iii) hierarchical clustering (e.g. HOPACH method) 
(Ganesh et al., 2004, Salomonis et al., 2005), iv) functional organization of genes into 
pathways networks with the aid of integrated databases like the Gene Ontology consortium 
(Lewis, 2005) or the Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa, 1997, 
Kanehisa & Goto, 2000) and finally v) integrating genotype, transcription and clinical trait 
data, e.g. see (Salomonis et al., 2005). 
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The biases adopted in this review are several. We focused attention on genes expressed 
essentially in the “normal” human myometrium. One study has reported a direct comparison 
of the non-pregnant myometrium (NP) with the pregnant human myometrium at term not in 
labor (TNIL) (Rehman et al., 2003). It gives an overall picture of the changes that the uterine 
muscle undergoes in its adaptation to the gestation. Two studies have described the changes in 
gene expression in the myometrium in preterm patients not in labor (PT) versus patients at 
term not in labor (TNIL) (Bethin et al., 2003, Charpigny et al., 2003) and two additional 
studies have described the changes in gene expression in the myometrium in patients at term 
not in labor (TNIL) versus patients at term in labor (TIL) (Esplin et al., 2005, Havelock et al., 
2005). Other studies have not been compiled directly, either because they did not provide 
sufficient precise references on the genes being studied (i.e. lack of  GenBank or Unigene 
references), they considered other components of the utero-fetal unit (i.e. membranes, 
decidua, cervix, etc.) or they were carried out on animal species. To translate lists of tens or 
hundreds of genes found to be differentially regulated in the conditions under study into a 
clearer understanding of the biological phenomena involved, we used both combinations of 
searches through the literature referenced in public databases and the Onto-Tools software 
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developed by the Draghici’s group at Wayne State University, Detroit (MI), 
(http://vortex.cs.wayne.edu/Projects.html). The Onto-Express module helps recognizing 
functional profiles (using Gene Ontology terms) for the categories: biochemical function, 
biological process, cellular role, cellular component, molecular function, and chromosome 
location (Draghici et al., 2003). The Pathway-Express module helps data mining, by 
proposing on the basis of a computational method a hierarchical list of several KEGG 
pathways (Kanehisa, 1997, Kanehisa & Goto, 2000) most likely adjusted to changes observed 
in microarray experiments (Khatri et al., 2005). Drawbacks and limitations inherent to the use 
of these tools or of their cognate alternatives for ontological analysis, have been reviewed 
recently (Khatri & Draghici, 2005). 
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The variations of myometrium gene expression in the course of gestation could be dispatched 
in 14 main KEGG pathways (http://www.genome.jp/kegg/pathway.html) that were the most 
representatives for the changes seen in non-pregnant (NP) versus term quiescent pregnant 
uterus (TNIL), quiescent preterm (PT) versus term quiescent uterus (TNIL) and term 
quiescent uterus (TNIL) versus contracting uterus at labor (TIL). Tables 1-4 and Figures 1-2 
summarize the compiled data which are commented below in more details. Wherever 
possible, OMIM nomenclature has been adopted in the text and tables 
(http://www.ncbi.nlm.nih.gov/omim/). 
 
Changes in structural and contractile genes during gestation 
 
Actin cytoskeleton, focal adhesion, adherens and tight junctions related genes represent a 
large subset of genes that are over-expressed in the pregnant human myometrium as 
compared to the non-pregnant state (Table 1). 
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Regulation of actin cytoskeleton 
 
Growth and cytoskeletal remodeling of myometrial cells during pregnancy are critical for 
myometrial functions including those expressed during labor and delivery. At term, signals 
that initiate labor, ultimately promote a switch in the phenotype in the quiescent uterus to a 
smooth muscle which becomes spontaneously active, excitable, highly responsive to uterine 
agonists, and exhibits a high degree of cell-cell coupling. Myometrial cells are rich in actin 
microfilaments, intermediate filaments and microtubules that allow cells to adapt to a variety 
of shapes and to carry out coordinated and directed movements. In rat, myometrial expression 
of alpha-actin is high throughout pregnancy. An increased expression of gamma-actin and its 
translocation to the membrane is observed in uterine myocytes at late gestation. Therefore, the 
alteration in myometrial composition of contractile proteins is important to prepare the 
myometrium for the development of contractions during labor (Shynlova et al., 2005).  
 
RhoA, a member of the Ras superfamily, and its downstream mediator RhoA kinase 
(ROCK1) are necessary for agonist-induced stress fiber formation (Gogarten et al., 2001). 
The higher expression of protein kinase C (PKC) isoforms observed in pregnant versus non-
pregnant myometrium (Rehman et al., 2003) may promote or drive the formation of stress 
fibers. Additionally, up-regulation of ROCK1 has been demonstrated in human term 
myometrium (Moore et al., 2000, Rehman et al., 2003). This leads to the idea that increased 
endogenous ROCK1 activity, resulting in enhanced RhoA-mediated calcium sensitization, is 
involved in the increased contractility at the time of labor. It is of note that EGF increases the 
presence of actin and myometrial EGF receptors transcripts are increased at the time of 
parturition (Charpigny et al., 2003, Gargiulo et al., 1997, Rehman et al., 2003).  
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Focal adhesion 
 
The transmission of force between the contractile apparatus of the cell and extracellular 
matrix (ECM) occurs at membrane-associated dense plaques or “focal adhesions”. Focal 
adhesions consist of clusters of integrins that mediate interactions between the extra- and 
intracellular environments. The cytoplasmic regions of integrins connect with cytoskeletal 
elements and signaling components such as Focal Adhesion Kinase (FAK), while the 
extracellular regions connect to specific extracellular matrix molecules such as collagen, 
laminin or fibronectin.  
 
Fetal growth imposes mechanical tension on the myometrium at term, which in turn induces 
activation of FAK leading to focal adhesion turnover and supporting myometrial cell 
hypertrophy. During late pregnancy, a fall in tyrosine phosphorylation of FAK and 
stabilization of focal adhesions occur for provoking the cessation of myometrial hypertrophy. 
Because actin polymerization and the dynamic remodeling of the actin cytoskeleton play key 
roles in the regulation of myometrial contraction, there is growing evidence that stretching 
induce labor, probably through a change in the expression of contraction-associated-proteins 
(CAPs) (Macphee & Lye, 2000). In human term pregnant myometrium, changes in 
cytoskeletal organization support a role for FAK and other focal adhesion-associated proteins 
as regulators of actin dynamics. ITGA5 with its known partner ITGB1, is up-regulated in rat 
myometrium during late pregnancy and labor (Williams et al., 2005) as well as ITGAV in the 
TNIL human myometrium (Rehman et al., 2003). Therefore they may interact with actin-
binding proteins (e.g. actinin and filamin) to form mechanical links to the cytoskeleton. A 
strong expression of vinculin is concentrated at actin-vinculin focal adhesion sites in human 
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myometrial cells (Yu & Lopez Bernal, 1998). At the time of parturition, expression of 
integrins declines and the focal adhesion and related pathways do not change in studies which 
compare the TNIL and TIL states of pregnancy (see Table 1).  
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Parturition as an inflammatory process 
 
Cytokine-chemokines interaction 
 
There is a massive influx in the myometrium of neutrophils, macrophages and T-lymphocytes 
concomitant with the onset of labor (Osman et al., 2003). An increase in cytokines, 
interleukin-1 (IL-1), IL-6, IL-8 and tumor necrosis factor (TNF)-alpha within tissues of the 
laboring uterus and cervix is demonstrated. 
 
Chemokines enhance inflammation by inducing chemotaxis and cell activation of 
inflammatory cells. CXC-Chemokines, attract neutrophils but not macrophages, while CC-
Chemokines preferentially induce migration of macrophages. Chemokine transcripts increase 
in myometrium at term, including CCL13 (MCP-4 or Monocyte chemotactic protein-4), 
CCL19, CCL21, CXCR4 (NPYRL or neuropeptide Y receptor-like) and CXCR5 (Burkitt 
lymphoma receptor) (Bethin et al., 2003, Charpigny et al., 2003, Rehman et al., 2003). At the 
time of labor, a selective increase in CXCL10 (Interferon-inducible protein-10), CCL8 and 
CC13 is noted (Esplin et al., 2005) (see Table 2). IL-8, MCP-1 and RANTES are regulated by 
local growth factors and cytokines such as TNF-alpha, interferon-gamma, and IL-1. IL-8 also 
potentiates the effect of IL-1-induced myometrial contractions through PGE2 production at 
the time of parturition and up-regulates myometrial TGF-beta receptors expression in vitro, 
suggesting an additional autocrine-signaling pathway. Therefore, it is clear that coordination 
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of chemokine-chemokine receptor interactions plays an important role in successful 
pregnancy (Kayisli et al., 2002). 
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The TNF receptor super family member Fas and its cognate ligand (FasL) play a role in cell 
leiomyoma apoptosis (Wang Y. et al., 2002). Therefore increased expression of TNFRS6 (i.e. 
Fas receptor) in term myometrium (Table 2) await consideration in the control of the uterine 
growth process. Elevated expression of TNFRS11B is observed in human myometrium with 
or without labor (Esplin et al., 2005, Rehman et al., 2003). A peak in uterine osteoprotegerin 
(i.e OPG or TNFRS11B), a soluble membrane of the TNF-alpha receptor family that acts as a 
negative regulator for receptor activator of nuclear factor-kB (RANK), has been reported 
during labor in the rat (Girotti & Zingg, 2003). 
 
The gp130 protein is a subunit component of several cytokines receptors including those for 
LIF. Cytokines sharing the gp130 (or IL6ST) subunits are referred to as IL6 type family of 
cytokines and signal through JAK/STAT pathway (Heinrich et al., 1998). They play a role in 
the regulation of gene activation, proliferation and differentiation. Down-regulation of IL6ST 
and LIF receptor at term (Table 3) may be an indication of the decrease of proliferation 
processes before the onset of labor. 
 
IFN-gamma inhibits the proliferation of vascular smooth muscle cells and the synthesis of 
collagens by myofibroblasts. In human myometrial cells, interferon gamma antagonizes IL-
1beta-induced prostaglandin-endoperoxide synthase 2 (COX-2 or PTGS2) expression and 
PGE2 production (Hertelendy et al., 2002). Therefore, the decrease in IFNGR1 transcript 
observed during the transition from PT to TNIL states of the uterus (Table 2), could be 
interpreted as an ad hoc evolution for labor onset. 
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TLR signaling pathway 
 
Toll-like receptors (TLRs) are evolutionarily conserved pathogen-associated microbial 
patterns and play important roles in innate immunity in mammals. Ten TLRs are evidenced in 
the uterus but TLR2 and TLR4 mRNA are expressed at the highest levels. Among the TLR-
related gene transcripts, SOCS, CD14 and IRAK mRNAs (see Tables 2 and 4) are widely 
expressed in the myometrium (Nishimura & Naito, 2005). TLR4 mediates induction of PTL 
in mice treated with lipopolysaccharide (LPS) (Wang H. & Hirsch, 2003). In monocytes, 
LPS-induced signaling through TLRs, lead to the recruitment of docking proteins such as IL-1 
receptor-associated kinase (IRAK) and TNF-alpha receptor-associated factor (TRAF6) 
leading to the activation of IkappaB kinase (IKK) complex. These pathways in turn activate 
transcription factor such as NF-kB that coordinates the induction of genes encoding 
inflammatory mediators (Guha & Mackman, 2001). In human pregnant myometrial cells a 
positive immunoreactivity for TLR4 is observed and cells exposure to LPS lead to nuclear 
translocation of the p65 subunit of NFkB (Dallot et al., 2005). The increased expression of 
CD14 together with increased expression of the catalytic subunit of PI3K in pregnant 
myometrium may serve to increase host protection against microbial invasion (Rehman et al., 
2003). At the end of pregnancy, because some of the TLR-related genes such as IRAK, IKK, 
MKK have decreased expression compared to earlier stage of the gestation (Charpigny et al., 
2003), it is possible that adaptative responses to immune or growth processes take place.  
   
TGF-beta signaling pathway 
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TGF-beta regulates its own expression, the expression of ECM, of matrix metalloproteinases 
(MMP), and of tissue inhibitor of matrix metalloproteinases (TIMP) as well as the growth of 
leiomyomas and of normal myometrial cells (Chegini et al., 1999). TGF-beta receptors 
mediate their action through multiple pathways, including smad proteins that convey TGF-
beta receptor signals from the cell surface to the nucleus, resulting in transcriptional activation 
of TGF-beta-responsive genes. TGF-beta also activates mitogen-activated protein kinase 
(MAPK), PKC, and calcium/calmodulin complex, inducing Smad-independent transcriptional 
responses. One mechanism by which TGF-beta is activated involves thrombospondin 
(THBS1). THBS1 promotes replication of smooth cells and modifies responses to contractile 
agents. THBS1 expression and protein in human myometrial tissues are increased during 
labor and after the administration of OT (Morimoto et al., 1998). Myometrial transcripts of 
THBS1 and THBS2 increases during pregnancy (Charpigny et al., 2003, Rehman et al., 2003) 
and peak at the time of labor concomitantly with the expression of TGF-beta (Esplin et al., 
2005). It is possible that the control of the TGF-beta pathway in the near term myometrium 
facilitates the transition of the quiescent uterus towards a contractile state, as well as it 
contributes to control the uterine growth.  
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Wnt signalling pathway 
 
Leiomyomas have high levels of both transcripts of WNT5B and of secreted frizzled related 
protein 1 (SFRP1), a modulator of Wnt signaling (Mangioni et al., 2005). Strong SFRP1 
expression under high estrogenic conditions seems to contribute to the development of uterine 
leiomyomas through the antiapoptotic effect of SFRP1 (Fukuhara et al., 2002). The increased 
expression of WNT5B in the pregnant myometrium suggests that the Wnt pathway is 
important in myometrial adaptation to pregnancy by decreasing apoptotic myometrial cell 
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death (Rehman et al., 2003). Inversely, other genes associated with the inhibition of cell 
proliferation such as p53 are increased at the end of gestation (Charpigny et al., 2003). 
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Kinases located at the crossroad of uterine contractility and myometrial cell 
proliferation 
  
MAPK-signaling pathway 
 
MAPK signaling cascades regulate diverse processes ranging from contraction, proliferation, 
differentiation, and development. Five families of MAPKs have been defined in mammalian 
cells: i) extracellular signal-regulated kinases (ERK1 and ERK2), ii) Jun N-terminal kinases 
(JNK), iii) p38 kinase isozymes. ERK1 and ERK2 are activated by mitogenic stimuli such as 
growth factors, cytokines and phorbol esters. Members of the JNK family play crucial roles in 
regulating responses to various stresses and apoptosis. Among the targets of p38 MAPKs are 
several transcription factors, including NF-κB, p53 and ATF2, which modulate the expression 
of genes encoding inflammatory cytokines (Qi & Elion, 2005). MAPKs are involved in 
inhibiting gap-junction-mediated cellular communication in rat myometrium (Loch-Caruso et 
al., 2003). Mechanical stretch of the rat uterus stimulates myometrial cell hypertrophy 
(Douglas et al., 1988) via a mechanism involving integrin/focal adhesion/MAPK cascades 
(Macphee & Lye, 2000). Activation of MAPKs is necessary for optimal stretch-induced c-fos 
expression (Oldenhof et al., 2002). In addition, the spatial expression of MAPK p38 and 
ERK-1/2 in conjunction with ATF2 isoforms within the uterine corpus during pregnancy and 
labor is likely to be important in preparation of the uterus for labor (Otun et al., 2005).  
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In the myometrium, the MAPK pathways are also implicated in the induction of PTGS2 
expression (Bartlett et al., 1999, Sooranna et al., 2004) and in mediating the effects of 
prostaglandins (PGs) (Ohmichi et al., 1997), OT (Zhong et al., 2003), endothelin-1 (ET-1) 
(Kimura et al., 1999) and corticotropin-releasing hormone (CRH) (Grammatopoulos et al., 
2000, Papadopoulou et al., 2004). Increasing maternal plasma levels of CRH during the last 
weeks of pregnancy and the substantial expression of CRH receptors in choriodecidua, 
placenta and myometrium suggests that this stress hormone plays a role in the control of 
human parturition (Sehringer et al., 2004).  
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MAPK activity increases in the rat myometrium from day 15 to day 20 of gestation and 
declines sharply just before parturition (Robin et al., 2004). During the same interval, a shift 
in intracellular distribution of the Ras protein precedes the down-regulation of membrane-
dependent mitogenic signaling and uterine hypertrophy as pregnancy approaches parturition 
(Ruzycky, 1998). During RU-486-induced PTL, as previously described for spontaneous 
labor, ERK phosphorylation levels increase, as does phosphorylation of caldesmon and of 20-
kDa MLC. When rats are chronically treated with an agent that prevents ERK activation, the 
onset of PTL is delayed (Li et al., 2004, Liu et al., 2004). 
 
OT-mediated ERK1/2 activation in myometrial cells involves a phospholipase C (PLC)-
independent pathway (Zhong et al., 2003). A cross-talk between growth factors receptors and 
the estrogen receptor alpha (ESR1) has been proposed. The estrogen response involves 
estradiol (E2)-ESR1-mediated responses as well as responses resulting from convergence of 
growth factor and ESR1-initiated activities (Hewitt et al., 2005). Functional signaling 
proximal to IGF-1R is maintained in the ER alpha-KO mouse uterus. ER alpha is necessary 
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for IGF-1 induction of uterine nuclear proliferative responses, and a cross-talk between IGF-
1R and ER signaling pathways exists in vivo (Klotz et al., 2002).  
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Protein kinase C 
 
PKC constitute a multigene family located at the crossroad of two essential uterine functions, 
namely contractility and cell proliferation. Six isoforms of PKC, the conventional PKC 
isoforms (alpha, betaI, betaII, and gamma), the novel PKC isoforms (delta, epsilon, theta, eta, 
lambda/iota) and the atypical PKC isoform (zeta) are evidenced in the human pregnant 
myometrium. Whereas PRKCA is required for proliferation of human myometrial cells (Eude 
et al., 2002), only activation of PRKCZ results in actin reorganization and elicits 
contractions of the human myometrium at the end of pregnancy (Di Liberto et al., 2003). 
 
A balance between T helper (Th1) (pro-inflammatory) / Th2 (anti-inflammatory) cytokine 
production, has been described at the time of parturition, and a link between TNF-
alpha/IL1-beta and premature human childbirth has been proposed (Arntzen et al., 1998). 
Because, atypical PKC’s are important components of the TNF/IL1B signaling pathway that 
controls NF-κB activation, the implication of the PRKCZ in the control of the onset of 
labor in women is not surprising. (Ozaki et al., 2003) also demonstrated that the levels of 
mRNA of PRKCB1 isoform in pregnant human myometrium were greater than those in 
nonpregnant myometrium, a feature confirmed in genomic studies (Table 3) (Rehman et al., 
2003). The levels of the phosphorylated substrate for PKC, CPI-17 which is considered to 
inhibit myosin light chain phosphatase were also greater in the pregnant myometrium. These 
results suggest that the PKC-mediated contractile mechanism is augmented in human 
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myometrium after gestation, and that this augmentation may be attributable to the increased 
activity of the PRKCB1 isoform and CPI-17. 
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Phosphatidyl inositol signaling pathway 
 
The PI3-kinase cascade is activated through the binding of the regulatory subunit to 
phosphorylated tyrosine residues, leading to enhanced activity of the catalytic subunit. PI3 
kinase phosphorylates phosphatidyliositol-4,5-bisphosphate (PIP2) to generate PIP3 which 
interacts with protein kinase Akt or protein kinase B (PKB). Activation of Akt influences 
many cellular functions through PIP3 binding and phosphorylation by phosphoinositide-
dependent kinase 1(PDK1). It includes cytoskeletal organization, cell growth, motility, 
proliferation and survival. PDK1 is known to phosphorylate PKC-zeta in the activation loop. 
PI3 kinase is also activated by direct binding of the catalytic subunit to activated Ras and PI3 
kinase cascade activation can lead to the activation of the ERK cascade (Stein & Waterfield, 
2000).  
 
Increases in [Ca2+]i are controlled by multiple signal pathways in myometrium. GPCR-
mediated stimulation of the Gq/11 subfamily and subsequent activation of PLC subfamily 
results in generation of IP3, which triggers release of Ca2+ from intracellular stores.  
Five PLC isoforms: beta 1, beta 2, beta 3, gamma 1, and gamma 2 are detected in human 
myometrium. OT activates human myometrium by interacting with at least two G proteins 
and possibly three PLC beta isoforms (Phaneuf et al., 1996). Indeed, the amount of PLCB4 is 
increased at midpregnancy, whereas PLCB1, PLCB2, and PLCB3 are up-regulated at term in 
the rat uterus (Mhaouty-Kodja et al., 2004). PLCB3 may be targeted by both contractant and 
relaxant signaling pathways in myometrium and play a critical role in the balance between 
H
al author m
anuscript    inserm
-00112636, version 1
  17
them (Zhong et al., 2005). Both DAG-sensitive PKC, activated by PLCB products, and DAG-
insensitive PKC, possibly activated by PI3kinase-dependent process are involved in ERK 
activation  to modulate rat uterine functions (Robin et al., 2002). In addition, protein tyrosine 
kinase/phosphatase activities may control both phosphorylation and activation of PLCG1 and 
contribute to the modulation of the generation of inositol phosphates and uterine tension.  
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Genomic studies exploring the transition from the NP to the TNIL state found an up-
regulation of the transcripts pertaining to the phosphoinositol signaling pathway (Rehman et 
al., 2003), whereas those comparing the PT to the TNIL state found a down-regulation of 
transcript expression (Bethin et al., 2003, Charpigny et al., 2003). This may be interpreted as 
a slowdown of myometrial cell proliferation processes when pregnancy comes close to term 
(Table 3). 
   
 Apoptosis and parturition 
 
Proliferation of smooth muscle cells and fibroblasts occurs in early pregnancy and decreases 
as the uterus nears parturition. In late pregnancy and during involution of the rat uterus, an 
increase of apoptosis is observed (Leppert, 1998). However, the extent of apoptosis or 
dedifferentiation that may occur in human myometrial cells during post-partum involution is 
still unknown. The most investigated factors linked to apoptosis are the Fas ligand (FasL), Fas 
receptor (FasR), the TNFalpha and its receptors. Some of the genes associated with the 
inhibition of cell proliferation and differentiation are increased in the myometrium at the end 
of pregnancy (Table 4). For an example, the TNFR6 or Fas antigen and the p53 tumor 
suppressor limit cellular proliferation by inducing cell cycle arrest and apoptosis. The 
presence of DFFA (DNA fragmentation factor-45), known to be essential for chromatin 
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condensation during normal apoptosis and the inhibition of the PI3kinase in the term pregnant 
myometrium, may also contribute to an increase of apoptotic events. 
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 G-protein signaling and parturition 
 
The silencing of the myometrial contractile function is conditioned by a predominant 
functional cAMP/cGMP system, whereas contractions are under the control of agonist-
induced calcium mobilization via the PLC pathway. Gestational-related modifications of 
GPCR in the myometrium, as well as changes in their associated kinases (GRK), cognate G 
proteins, and effectors have been detected (Hertelendy & Zakar, 2004, Lopez Bernal & 
TambyRaja, 2000). Some GPCRs coupled to PLC generates the second messengers IP3 and 
DAG. The ensuing rise in IP3 releases Ca2+ from the sarcoplasmic reticulum, causing a 
sudden rise in intracellular calcium, whereas DAG activates PKC and the MAPK cascades. 
Uterine contractility can also be enhanced via the activation of Rho GTPases, and the 
subsequent action of ROCK’s to potentiate the effect of myosin light chain kinase (MYLK). 
These pathways have been discussed above. Other GPCR coupled to the adenylyl cyclase 
promotes the accumulation of cAMP which controls the relaxation of the myometrium during 
pregnancy via the inactivation of MYLK and the activation of ATF-2 (Bailey & Europe-
Finner, 2005). Another powerful way for increasing cAMP concentration consists in 
inhibiting its hydrolysis by phosphodiesterases (PDEs). Among the five PDE families (PDE 1, 
2, 3, 4 and 5) identified in the human myometrium (Leroy et al., 1994, Leroy et al., 1999), 
one particular isoform, PDE4B2, which specifically hydrolyses cAMP is selectively induced 
at the end of pregnancy suggesting a role for this protein in the setting of the contractile state 
of the myometrium just before delivery (Mehats et al., 2001, Mehats et al., 2000).  
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Neuroactive-ligands and parturition 421 
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A small selection of peptides, neuroactive factors and ion channels such as ET-1, 
noradrenaline, NPY, PGE2, GABA… that mediate uterine relaxation or contraction and act 
through GPCR are mentioned here (see Table 4). ET-1 exerts a stimulatory effect on 
myometrium contractility and proliferation. Its transcript is up-regulated in the pregnant 
myometrium (Rehman et al., 2003). Among the three subtypes of alpha2-adrenoceptors found 
in the human myometrium at term pregnancy (Adolfsson et al., 1998), only the alpha2C-
subtype appears to be predominant in pregnant myometrium. Stimulation of GABA (A) 
receptors tonically inhibits contractions of the rabbit myometrium, while stimulation of 
GABA (B) receptors enhances contractions. Steroids interact with GABA (A) receptors to 
modulate uterine contractility (Majewska & Vaupel, 1991). The subunit composition of 
GABA (A) receptor differs in rat uteri throughout gestation and just before labour in humans, 
a decline in GABA receptor transcripts is observed (Bethin et al., 2003, Charpigny et al., 
2003). TRH-R is expressed in term myometrium. (Fukusumi et al., 1995) have previously 
reported high level of TRH-R mRNA in uterus but whether TRH plays an important role in 
the female reproductive tract remains to be elucidated. PGs, in conjunction with their 
numerous receptors activate multiple signaling pathways and exert multifaceted actions in 
myometrium (Hertelendy & Zakar, 2004). Thus, EP3 transcripts are down-regulated in the 
term pregnant myometrium (Bethin et al., 2003, Charpigny et al., 2003). However, the 
significance of these changes remains to be established, because of the known existence of 
EP3 splice variants.  
 
Future strategies for integrative analysis of myometrial functions 
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A question is what could be the composition of an “ideal” genomic array for the study of 
parturition? The answer is not unique. Undedicated or "generic" microarrays seem 
heuristically more potent to explore and detect new interesting metabolic pathways than 
specialized arrays could do (Tierney et al., 2003). Inversely, a myometrium-dedicated 
microarray is unlikely to provide essential clues on the mechanisms of parturition for the 
following reasons. 
446 
447 
448 
449 
450 
451 
452 
453 
454 
455 
456 
457 
458 
459 
460 
461 
462 
463 
464 
465 
466 
467 
468 
469 
470 
 
Gene module analysis, as exemplified in this review, searches for coordinate regulation of 
genes that belong to a priori defined gene modules. A statistical test performed for each 
module relative to all other genes on the microarray calculates whether the degree of 
coordinate regulation is more than one would expect by chance. Therefore, a module of genes 
involved in a physiological process may be significantly down-regulated whereas each gene 
in the module under study may be transcriptionally down regulated by say only 20%, and thus 
not clearly detected at the individual gene level (Tierney et al., 2003, Wong & Chang, 2005). 
In addition, beside classical ideas regarding trans-regulation of gene expression, a greater 
number of hypotheses generated from regulatory networks analysis or cis-regulatory DNA 
elements analysis can be validated today in a high throughput fashion using chromatin-
immunoprecipitation followed by microarray analysis (ChIP-chip). For example, a large 
fraction of genes transcribed in the liver and pancreas have been found to bind HNF4, 
providing a molecular explanation for the role of HNF4 mutations and polymorphisms in 
hereditary and sporadic forms of diabetes mellitus (Odom et al., 2004). 
  
In majority, transcripts are not tissue-restricted, but are present to varying degrees in a wide 
variety of cell types although there are exceptions, like myosin heavy chain which is primarily 
found in smooth muscle cells. As such, it is not necessary to create arrays only from cDNAs 
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obtained from dedicated libraries. Many sources of clones can be used for array analyses 
including microarrays purchased from companies (e. g. Incyte, Affymetrix, Clontech, etc.), 
which consist of cDNA clones or oligonucleotides that cover a large percentage of the 
transcripts (known and ESTs) present in public databases (Juhasz et al., 2002). Only in the 
context of a well defined cell population, DNA microarray data can be used in a 
comprehensive analysis aimed at identifying the shared and unique molecular 'modules' 
underlying a pathological process. Thus, in peripheral organs, laser microdissection of their 
several constitutive compartments may reveal distinct repertoires of apoptosis-associated 
genes, chemokines and chemokine receptors in these compartments (Shen et al., 2004). 
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The microarray technology made possible to widen our comprehension of the major structural 
and metabolic transformations which affect the myometrium from the very beginning of 
pregnancy until parturition. The results have proven to be coherent with the mass of 
information which was accumulated previously, primarily on the basis of the study of selected 
critical factors. Although still limited in number, the recent studies highlight the activation of 
precise signaling pathways, some of which may had been under evaluated. Thus, the 
remodelling and maturation processes that the uterus undergoes in pregnancy appear clearly 
as phenomenon’s which last during the full course of gestation. This is attested by the nature 
of best represented signaling pathways, in comparisons of the non pregnant-uterus versus 
term uterus and the comparisons of the preterm uterus versus the term uterus in labor. 
Comparatively, the onset of labor is perhaps the phenomenon which remains the least well 
described by these methods of analysis, possibly because it is a phenomenon occurring in a 
too short window to have been grasped by the few studies carried out up to now. Whatever it 
may be, genomic studies constitute a necessary first step of orientation which should lead to a 
more elaborate hierarchical vision of the physiological mechanisms of gestation, in particular 
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by establishing new links between the generic signaling pathways that are activated during the 
normal or pathological gestation. Genomic studies also represent an indicative step that will 
need to be correlated with a systematic proteomic analysis of the myometrium. The latter will 
undoubtedly develop in a very near future. 
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Building comprehensive strategies of genomic and proteomic analysis to explore physiologic 
functions remains today a challenge to which very few research groups have devoted their 
energy, and so far only for biological functions unrelated to the pregnant uterus. The 
examples reported today indicate that this will be hardly accessible without the integrated 
cooperation of several groups (Ho et al., 2003).  
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Figure 1  
 
Main KEGG pathways (http://www.genome.jp/kegg/) represented in the myometrium on the 
basis of the genes detected in genomic studies. Gene transcripts pertaining to these pathways 
were either up-regulated (red) or down-regulated (green) by a two fold or more factor. White 
boxes denote insufficiently documented links in context. See Tables 1-4 for details. (A) 
Comparison between the non-pregnant  (NP) and term not in labor (TNIL) uterus (Rehman et 
al., 2003). (B) Comparison between the preterm (PT) uterus and term in labor uterus (TNIL) 
(Bethin et al., 2003, Charpigny et al., 2003) or between TNIL and term in labor uterus (TIL) 
(Esplin et al., 2005, Havelock et al., 2005). Five pathways (Focal adhesion, MAPK, TGF-
beta, JAK-STAT and apoptosis) are shown with their known links to membrane receptors 
(Wnt, TGF-beta, cytokines and Toll-like receptors). Three additional pathways (actin 
cytoskeleton, phosphatidylinositol and calcium signaling are over-expressed in gestation by 
comparison to the non-pregnant state. THBS1, thrombospondin-1 (inhibitory). 
 
Figure 2  
 
Main KEGG pathways (http://www.genome.jp/kegg/) represented in the myometrium on the 
basis of the genes detected in genomic studies. Gene transcripts pertaining to these pathways 
were either up-regulated (red) or down-regulated (green) by a two fold or more factor. White 
boxes denote insufficiently documented links in context. See Tables 1-4 for details. (A) 
Comparison between the non-pregnant  (NP) and term not in labour (TNIL) uterus (Rehman 
et al., 2003). (B) Comparison between the preterm (PT) uterus and term in labor uterus 
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(TNIL) (Bethin et al., 2003, Charpigny et al., 2003) or between TNIL and term in labor uterus 
(TIL) (Esplin et al., 2005, Havelock et al., 2005).  Ten pathways (focal adhesion, adherens 
junctions, tight junctions, actin cytoskeleton, phosphatidylinositol and calcium signaling, 
MAPK, TGF-beta, JAK-STAT and apoptosis) are shown with their known links to cytokine, 
growth factors (GF) and G-protein coupled membrane receptors. CAMs, cell adhesion 
molecules, ECM, extra-cellular matrix. 
 
26 
27 
28 
29 
30 
31 
32 
H
al author m
anuscript    inserm
-00112636, version 1
  
40
 
Fi
gu
re
 1
 
    
TH
B
S
1
M
AP
K
p3
8
Ac
tin
cy
to
sk
el
et
on
TG
F-
β
si
gn
al
in
g
Ph
os
ph
at
id
yl
in
os
ito
l
Ja
k-
ST
AT
C
al
ci
um
si
gn
al
in
g
Ap
op
to
si
s
C
yt
ok
in
es
re
ce
pt
or
s
W
nt
TG
F-
β
TL
R
Fo
ca
l A
dh
es
io
n
(A
)
TH
B
S
1
M
AP
K
p3
8
A
ct
in
cy
to
sk
el
et
on
TG
F-
β
si
gn
al
in
g
Ph
os
ph
at
id
yl
in
os
ito
l
JA
K-
ST
AT
C
al
ci
um
si
gn
al
in
g
Ap
op
to
si
s
p5
3
C
yt
ok
in
es
re
ce
pt
or
s
W
nt
TG
F-
β
TL
R
Fo
ca
l A
dh
es
io
n
(B
)
N
P
TN
IL
PT
TN
IL
 o
r T
IL
TH
B
S
1
M
AP
K
p3
8
Ac
tin
cy
to
sk
el
et
on
TG
F-
β
si
gn
al
in
g
Ph
os
ph
at
id
yl
in
os
ito
l
Ja
k-
ST
AT
C
al
ci
um
si
gn
al
in
g
Ap
op
to
si
s
C
yt
ok
in
es
re
ce
pt
or
s
W
nt
TG
F-
β
TL
R
Fo
ca
l A
dh
es
io
n
(A
)
TH
B
S
1
M
AP
K
p3
8
A
ct
in
cy
to
sk
el
et
on
TG
F-
β
si
gn
al
in
g
Ph
os
ph
at
id
yl
in
os
ito
l
JA
K-
ST
AT
C
al
ci
um
si
gn
al
in
g
Ap
op
to
si
s
p5
3
C
yt
ok
in
es
re
ce
pt
or
s
W
nt
TG
F-
β
TL
R
Fo
ca
l A
dh
es
io
n
(B
)
N
P
TN
IL
PT
TN
IL
 o
r T
IL
H
al author m
anuscript    inserm
-00112636, version 1
  
41
 
Fi
gu
re
 2
 
  
EC
M
-re
ce
pt
or
in
te
ra
ct
io
n
C
AM
 
lig
an
ds
C
yt
ok
in
es
 / 
G
F
N
eu
ro
ac
tiv
e
lig
an
ds
Io
n 
ch
an
ne
ls
lig
an
ds
M
AP
K
Ac
tin
cy
to
sk
el
et
on
TG
F-
be
ta
Ph
os
ph
at
id
yli
no
si
to
l
JA
K-
ST
AT
C
al
ci
um
si
gn
al
lin
g
Ap
op
to
si
s
Io
n
ch
an
ne
ls
G
PC
R
C
yt
ok
in
es
 / 
G
F
re
ce
pt
or
s
Ti
gh
t
Ju
nc
tio
ns
Ad
he
re
ns
Ju
nc
tio
ns
Fo
ca
l A
dh
es
io
n
C
AM
s
EC
M
-re
ce
pt
or
in
te
ra
ct
io
n
C
AM
 
lig
an
ds
C
yt
ok
in
es
 / 
G
F
N
eu
ro
ac
tiv
e
lig
an
ds
Io
n 
ch
an
ne
ls
lig
an
ds
M
AP
K
TG
F-
be
ta
Ph
os
ph
at
id
yli
no
si
to
l
JA
K-
ST
AT
C
al
ci
um
si
gn
al
lin
g
Ap
op
to
si
s
Io
n
ch
an
ne
ls
G
PC
R
C
yt
ok
in
es
 / 
G
F
re
ce
pt
or
s
Ti
gh
t
Ju
nc
tio
ns
Ad
he
re
ns
Ju
nc
tio
ns
Fo
ca
l A
dh
es
io
n
C
AM
s
Ac
tin
cy
to
sk
el
et
on
(A
)
(B
)
NP
TN
IL
PT
TN
IL
 o
r T
IL
EC
M
-re
ce
pt
or
in
te
ra
ct
io
n
C
AM
 
lig
an
ds
C
yt
ok
in
es
 / 
G
F
N
eu
ro
ac
tiv
e
lig
an
ds
Io
n 
ch
an
ne
ls
lig
an
ds
M
AP
K
Ac
tin
cy
to
sk
el
et
on
TG
F-
be
ta
Ph
os
ph
at
id
yli
no
si
to
l
JA
K-
ST
AT
C
al
ci
um
si
gn
al
lin
g
Ap
op
to
si
s
Io
n
ch
an
ne
ls
G
PC
R
C
yt
ok
in
es
 / 
G
F
re
ce
pt
or
s
Ti
gh
t
Ju
nc
tio
ns
Ad
he
re
ns
Ju
nc
tio
ns
Fo
ca
l A
dh
es
io
n
C
AM
s
EC
M
-re
ce
pt
or
in
te
ra
ct
io
n
C
AM
 
lig
an
ds
C
yt
ok
in
es
 / 
G
F
N
eu
ro
ac
tiv
e
lig
an
ds
Io
n 
ch
an
ne
ls
lig
an
ds
M
AP
K
TG
F-
be
ta
Ph
os
ph
at
id
yli
no
si
to
l
JA
K-
ST
AT
C
al
ci
um
si
gn
al
lin
g
Ap
op
to
si
s
Io
n
ch
an
ne
ls
G
PC
R
C
yt
ok
in
es
 / 
G
F
re
ce
pt
or
s
Ti
gh
t
Ju
nc
tio
ns
Ad
he
re
ns
Ju
nc
tio
ns
Fo
ca
l A
dh
es
io
n
C
AM
s
Ac
tin
cy
to
sk
el
et
on
(A
)
(B
)
NP
TN
IL
PT
TN
IL
 o
r T
ILH
al author m
anuscript    inserm
-00112636, version 1
